US court vacates Suboxone injunction

Dr Reddy’s Laboratories plans to resume its launch activities of the first generic of Indivior’s Suboxone (buprenorphine/naloxone) sublingual film formulation “as soon as permitted” after a US Court of Appeals vacated and remanded a district court’s preliminary injunction in a majority 2-1 decision. Appeals court judge Pauline Newman offered a dissenting opinion. As Generics bulletin went to press, Dr Reddy’s had not announced a launch.